What is Bioresource Technology?
Bioresource Technology is a manufacturer of high-quality In Vitro Diagnostic (IVD) products, emphasizing value, lot-to-lot consistency, and custom product development. Operating from a 26,000-square-foot ISO 13485:2003 certified facility in Weston, Florida, the company adheres to GMP standards for large-scale production in a cleanroom environment. With an experienced management team averaging 26 years in the IVD industry, Bioresource Technology is committed to research and development, timely order fulfillment, and building long-term customer relationships through dedicated attention and rapid response.
How much funding has Bioresource Technology raised?
Bioresource Technology has raised a total of $432K across 2 funding rounds:
Debt
$150K
Debt
$282K
Debt (2020): $150K with participation from PPP
Debt (2021): $282K led by PPP
What's next for Bioresource Technology?
The recent strategic investment positions Bioresource Technology for accelerated growth and enhanced market penetration. With a foundation built on robust manufacturing capabilities and a customer-centric approach, the company is poised to leverage this capital to further its R&D efforts, expand its product portfolio, and solidify its standing as a leading supplier of IVD products. Future developments are expected to focus on scaling production to meet increasing demand and potentially exploring new strategic partnerships to broaden its market reach.
See full Bioresource Technology company page
